ANALYSIS OF ANTICANCER POTENTIAL OF JACKFRUIT FLOUR COMPOUNDS: A COMPARISON WITH TAMOXIFEN FOR BREAST CANCER THERAPY
281 / 10
Keywords:
Breast cancer, Jack fruit, LCMS analysis, molecular docking, ADME analysisAbstract
Tamoxifen effectively prevents and treats estrogen-dependent breast cancers, Tamoxifen therapy carries a risk factor of developing endometrial tumors. Artocarpus heterophyllus Lam, popularly referred to as jackfruit, is a widely available fruit rich in natural bioactive compounds with promising anticancer potential. LCMS analysis of a methanolic extract from raw jackfruit flour revealed 563 compounds. Computational modeling simulations were conducted for these compounds using the Glide docking panel within Maestro 11.9 (Schrödinger Suite) to evaluate their binding affinity to the human estrogen receptor alpha ligand-binding domain (ERá LBD), with the structure of the GW5638-ERá LBD complex (PDB ID: 1R5K) serving as the reference. Fifty-two compounds successfully engaged with the Human Estrogen Receptor Alpha, urpassing a Glide score threshold of -5 (kcal/mol), with 48 of them achieving a Glide score equal to or higher than -5 (kcal/mol). Among these, Fluvastatin sodium (Lescol), Pravastatin sodium, and 1,7-bis(4-hydroxyphenyl)-5-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6- (hydroxymethyl)oxan-2-yl]oxyheptan-3-onedemonstrated impressive binding energies of -10.791,- 10.063 and -10.005, respectively, surpassing Tamoxifen’s binding energy of -9.856 in docking experiments. Besides, in ADME analysis Fluvastatin sodium exhibited superior ADME properties compared to Tamoxifen.This advantageous solubility profile and its promising docking scores positionfluvastatin sodium as a robust candidate warranting further consideration in breast cancer drug development.
References
1. Chemaxon. (n.d.). Retrieved on July 15, 2024,
2. from https://chemaxon.com
3. Daina, A., Michielin, O., and Zoete, V. 2017.
4. SwissADME: A free web tool to evaluate
5. pharmacokinetics, drug-likeness and
6. medicinal chemistry friendliness of small
7. molecules. Scientific Reports. 7(1): 42717.
8. Elimam, H.,El-Say, K. M., Cybulsky, A.V and
9. Khalil,H. 2020. Regulation of Autophagy
10. Progress via Lysosomal Depletion by
11. Fluvastatin Nanoparticle Treatment in
12. Breast Cancer Cells. ACS Omega. 5(25).
13. pp.15476–15486.
14. Emons, G., Mustea, A and Tempfer, C. 2020.
15. Tamoxifen and endometrial cancer: A
16. Janus-headed drug. Cancers. 12(9). pp.
17. 2535.
18. Fan, J., Fu, A and Zhang, L. 2019. Progress in
19. molecular docking. Quantitative Biology.
20. 7(2). pp.83–89.
21. Friesner, R. A., Murphy, R. B., Repasky, M. P.,
22. Frye, L. L., Greenwood, J. R., Halgren, T.
23. A ... and Mainz, D. T. 2006. Extra precision
24. glide: Docking and scoring incorporating
25. a model of hydrophobic enclosure for
26. protein” ligand complexes. Journal of
27. medicinal chemistry. 49(21). pp. 6177-
28. 6196.
29. Gupta, A., Marquess, A. R., Pandey, A. K and
30. Bishayee, A. 2023. Jackfruit (Artocarpus
31. heterophyllus Lam.) in health and disease:
32. a critical review. Critical reviews in food
33. science and nutrition. 63(23). pp.6344–
34. 6378.
35. Haleel, M. P. M., Rashid, K and Kumar, C. S.
36. 2018. Artocarpus Heterophyllus: Review
37. Study on Potential Activities. Research
38. Journal of Pharmacology and
39. Pharmacodynamics. 10(1). pp. 24.
40. Hassanpour, S. H and Dehghani, M. 2017.
41. Review of cancer from the perspective of
42. molecular. Journal of Cancer Research
43. and Practice. 4(4).pp.127–129.
44. Hu, R., Hilakivi-Clarke, L and Clarke, R. 2015.
45. Molecular mechanisms of tamoxifenassociated
46. endometrial cancer (Review).
47. Oncology Letters. 9(4). pp. 1495–1501.
48. Kanugula, A. K., Dhople, V. M., Völker, U.,
49. Ummanni, R and Kotamraju, S. 2014.
50. Fluvastatin Mediated Breast Cancer Cell
51. Death: A Proteomic Approach to Identify
52. Differentially Regulated Proteins in MDAMB-
53. 231 Cells. PLOS ONE. 9(9). e108890.
54. Chemaxon. (n.d.). Retrieved on July 15, 2024,
55. from https://chemaxon.com
56. Daina, A., Michielin, O., and Zoete, V. 2017.
57. SwissADME: A free web tool to evaluate
58. pharmacokinetics, drug-likeness and
59. medicinal chemistry friendliness of small
60. molecules. Scientific Reports. 7(1): 42717.
61. Elimam, H.,El-Say, K. M., Cybulsky, A.V and
62. Khalil,H. 2020. Regulation of Autophagy
63. Progress via Lysosomal Depletion by
64. Fluvastatin Nanoparticle Treatment in
65. Breast Cancer Cells. ACS Omega. 5(25).
66. pp.15476–15486.
67. Emons, G., Mustea, A and Tempfer, C. 2020.
68. Tamoxifen and endometrial cancer: A
69. Janus-headed drug. Cancers. 12(9). pp.
70. 2535.
71. Fan, J., Fu, A and Zhang, L. 2019. Progress in
72. molecular docking. Quantitative Biology.
73. 7(2). pp.83–89.
74. Friesner, R. A., Murphy, R. B., Repasky, M. P.,
75. Frye, L. L., Greenwood, J. R., Halgren, T.
76. A ... and Mainz, D. T. 2006. Extra precision
77. glide: Docking and scoring incorporating
78. a model of hydrophobic enclosure for
79. protein” ligand complexes. Journal of
80. medicinal chemistry. 49(21). pp. 6177-
81. 6196.
82. Gupta, A., Marquess, A. R., Pandey, A. K and
83. Bishayee, A. 2023. Jackfruit (Artocarpus
84. heterophyllus Lam.) in health and disease:
85. a critical review. Critical reviews in food
86. science and nutrition. 63(23). pp.6344–
87. 6378.
88. Haleel, M. P. M., Rashid, K and Kumar, C. S.
89. 2018. Artocarpus Heterophyllus: Review
90. Study on Potential Activities. Research
91. Journal of Pharmacology and
92. Pharmacodynamics. 10(1). pp. 24.
93. Hassanpour, S. H and Dehghani, M. 2017.
94. Review of cancer from the perspective of
95. molecular. Journal of Cancer Research
96. and Practice. 4(4).pp.127–129.
97. Hu, R., Hilakivi-Clarke, L and Clarke, R. 2015.
98. Molecular mechanisms of tamoxifenassociated
99. endometrial cancer (Review).
100. Oncology Letters. 9(4). pp. 1495–1501.
101. Kanugula, A. K., Dhople, V. M., Völker, U.,
102. Ummanni, R and Kotamraju, S. 2014.
103. Fluvastatin Mediated Breast Cancer Cell
104. Death: A Proteomic Approach to Identify
105. Differentially Regulated Proteins in MDAMB-
106. 231 Cells. PLOS ONE. 9(9). e108890.
Downloads
Published
Issue
Section
License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The author owns the article's copyright until the article is accepted for publication. After acceptance, the author(s) assigns the article's copyright jointly to both the authors and the Publishers of the Journal of Research ANGRAU (ANGRAU) and licensed under a Creative Commons Attribution-Non Commercial-Share Alike 4.0 International License.